Aurora Cannabis
Canadian cannabis company
ACB Toronto Stock Exchange · home listing
ACB NYSE
ISIN CA05156X1087 SEC CIK 1683541
Follow Aurora Cannabis
Weekly email: filings, results
Net income
−CAD 17.2M
EPS, diluted
-
Operating income
−CAD 24M
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | CAD 343.3M | CAD 1.6M |
| FY24 | CAD 269.6M | −CAD 69.3M |
| FY23 | CAD 221.3M | −CAD 1.7B |
| FY22 | CAD 245.3M | −CAD 692M |
| FY21 | CAD 268.7M | −CAD 3.3B |
| FY20 | CAD 245.5M | −CAD 293.5M |
| FY19 | CAD 55.2M | CAD 71.9M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 54.6% | 1.4% | 0.5% |
| FY24 | 48.9% | −16.7% | −25.7% |
| FY23 | 9.6% | −104.6% | −776% |
| FY22 | −8.8% | −115.3% | −282.2% |
| FY21 | −7.4% | −173.3% | −1221.7% |
| FY20 | 58% | −129.6% | −119.5% |
| FY19 | 78.8% | −173.5% | 130.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | −CAD 142.5M |
| FY22 | −CAD 263.7M |
| FY21 | - |
| FY20 | −CAD 606.5M |
| FY19 | −CAD 218.6M |
- Aurora Cannabis
- Healthcare median
Show the numbers
| Year | Aurora Cannabis | Healthcare median |
|---|---|---|
| FY25 | 0.5% | −30.6% |
| FY24 | −25.7% | −47% |
| FY23 | −776% | −58% |
| FY22 | −282.2% | −80.4% |
| FY21 | −1221.7% | −71.9% |
| FY20 | −119.5% | −62.2% |
| FY19 | 130.3% | −46.3% |